Tenascins and the importance of adhesion modulation

Cold Spring Harbor Perspectives in Biology

Volumn 3, Issue 5, 2011, Pages 1-19

  Chiquet Ehrismann, Ruth ^a   Tucker, Richard P ^b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORDATA;

TENASCIN; TRANSCRIPTION FACTOR;

ANIMAL; CANCER INVASION; CELL ADHESION; CELL MOTION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; METASTASIS; MOLECULAR EVOLUTION; MOUSE; PHYLOGENY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL ADHESION; CELL MOVEMENT; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHYLOGENY; SIGNAL TRANSDUCTION; TENASCIN; TRANSCRIPTION FACTORS;

EID: 84855165117     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a004960     Document Type: Article

References (177)

1. Ambort D, Brellier F, Becker-Pauly C, Stocker W, Andrejevic-Blant S, Chiquet M, Sterchi EE. 2010. Specific processing of tenascin-C by the metalloprotease meprinβ neutralizes its inhibition of cell spreading. Matrix Biol 29: 31-42.
2. Andjus PR, Bajic A, Zhu L, Schachner M, Strata P. 2005. Short-term facilitation and depression in the cerebellum: Some observations on wild-type and mutant rodents deficient in the extracellular matrix molecule tenascin C. Ann N Y Acad Sci 1048: 185-197.
3. Apostolova I, Irintchev A, Schachner M. 2006. Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice. J Neurosci 26: 7849-7859.
4. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knol C, Kirchner T, Jung A. 2005. β-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24: 8200-8204.
5. Borsi L, Allemanni G, Gaggero B, Zardi L. 1996. Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells. Int J Cancer 66: 632-635.
6. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, BignerDD. 1983. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43: 2796-2805.
7. Brack SS, Silacci M, Birchler M, NeriD. 2006. Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin Cancer Res 12: 3200-3208.
8. Brellier F, Tucker RP, Chiquet-Ehrismann R. 2009. Tenascins and their implications in diseases and tissue mechanics. Scand J Med Sci Sports 19: 511-519.
9. Brenneke F, Bukalo O, Dityatev A, Lie AA. 2004. Mice deficient for the extracellular matrix glycoprotein tenascin-r show physiological and structural hallmarks of increased hippocampal excitability, but no increased susceptibility to seizures in the pilocarpine model of epilepsy. Neuroscience 124: 841-855.
10. Bruckner G, Grosche J, Schmidt S, Hartig W, Margolis RU, Delpech B, Seidenbecher CI, Czaniera R, Schachner M. 2000. Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol 428: 616-629.
11. Brummendorf T, Hubert M, Treuber U, Leuschner R, Tarnok A, Rathjen FG. 1993. The axonal recognition molecule F11 is a multifunctional protein: Specific domains mediate interactions with Ng-CAM and restrictin. Neuron 10: 711-727.
12. Bukalo O, Schachner M, Dityatev A. 2001. Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 104: 359-369.
13. Bukalo O, Schachner M, Dityatev A. 2007. Hippocampal metaplasticity induced by deficiency in the extracellular matrix glycoprotein tenascin-R. J Neurosci 27: 6019-6028.
14. Burch GH, Gong Y, LiuW, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J. 1997. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome [see comments]. Nat Genet 17: 104-108.
15. Carnemolla B, Castellani P, Ponassi M, Borsi L, Urbini S, Nicolo G, Dorcaratto A, Viale G, Winter G, Neri D, et al. 1999. Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol 154: 1345-1352.
16. Chiquet-Ehrismann R. 1991. Anti-adhesive molecules of the extracellular matrix. Curr Opin Cell Biol 3: 800-804.
17. Chiquet-Ehrismann R, Chiquet M. 2003. Tenascins: Regulation and putative functions during pathological stress. J Pathol 200: 488-499.
18. Chiquet-Ehrismann R, Hagios C, Schenk S. 1995. The complexity in regulating the expression of tenascins. Bioessays 17: 873-878.
19. Chiquet-Ehrismann R, Kalla P, PearsonCA, Beck K, Chiquet M. 1988. Tenascin interferes with fibronectin action. Cell 53: 383-390.
20. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. 1986. Tenascin: An extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47: 131-139.
21. Chiquet M, Fambrough DM. 1984. Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol 98: 1937-1946.
22. Chiquet M, Sarasa-Renedo A, Tunc-Civelek V. 2004. Induction of tenascin-C by cyclic tensile strain versus growth factors: Distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim Biophys Acta 1693: 193-204.
23. Chung CY, Erickson HP. 1994. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126: 539-548.
24. Chung CY, Murphy-Ullrich JE, Erickson HP. 1996. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7: 883-892.
25. Cifuentes-Diaz C, Faille L, Goudou D, Schachner M, Rieger F, Angaut-Petit D. 2002. Abnormal reinnervation of skeletal muscle in a tenascin-C-deficient mouse. J Neurosci Res 67: 93-99.
26. Cifuentes-Diaz C, Velasco E, Meunier FA, Goudou D, Belkadi L, Faille L, Murawsky M, Angaut-Petit D, Molgo J, Schachner M, et al. 1998. The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. Cell Mol Biol (Noisy-legrand) 44: 357-379.
27. Cohen ED, Tian Y, Morrisey EE. 2008. Wnt signaling: An essential regulator of cardiovascular differentiation, morphogenesis and progenitor self-renewal. Development 135: 789-798.
28. Copertino DW, Edelman GM, Jones FS. 1997. Multiple promoter elements differentially regulate the expression of the mouse tenascin gene. Proc Natl Acad Sci 94: 1846-1851.
29. Cybulska-Klosowicz A, Zakrzewska R, Pyza E, Kossut M, Schachner M. 2004. Reduced plasticity of cortical whisker representation in adult tenascin-C-deficient mice after vibrissectomy. Eur J Neurosci 20: 1538-1544.
30. de Chevigny A, Lemasson M, Saghatelyan A, Sibbe M, Schachner M, Lledo PM. 2006. Delayed onset of odor detection in neonatal mice lacking tenascin-C. Mol Cell Neurosci 32: 174-186.
31. Degen M, Brellier F, Kain R, Ruiz C, Terracciano L, Orend G, Chiquet-Ehrismann R. 2007. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 67: 9169-9179.
32. Degen M, Brellier F, Schenk S, Driscoll R, Zaman K, Stupp R, Tornillo L, Terracciano L, Chiquet-Ehrismann R, Ruegg C, et al. 2008. Tenascin-W, a newmarker of cancer stroma, is elevated in sera of colon and breast cancer patients. Int J Cancer 122: 2454-2461.
33. della Gaspera B, Armand AS, Sequeira I, Lecolle S, Gallien CL, Charbonnier F, Chanoine C. 2009. The Xenopus MEF2 gene family: Evidence of a role for XMEF2C in larval tendon development. Dev Biol 328: 392-402.
34. Deryugina EI, Bourdon MA. 1996. Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 109: 643-652.
35. Egging DF, van Vlijmen-Willems I, Choi J, Peeters AC, van Rens D, Veit G, Koch M, Davis EC, Schalkwijk J. 2008. Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice. Cell Tissue Res 332: 523-532.
36. Egging DF, van Vlijmen I, Starcher B, Gijsen Y, Zweers MC, Blankevoort L, Bristow J, Schalkwijk J. 2006. Dermal connective tissue development in mice: An essential role for tenascin-X. Cell Tissue Res 323: 465-474.
37. Egging D, van Vlijmen-Willems I, van Tongeren T, Schalkwijk J, Peeters A. 2007. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition. Connect Tissue Res 48: 93-98.
38. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, Imanaka-Yoshida K. 2007. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol 211: 86-94.
39. Elefteriou F, Exposito JY, Garrone R, Lethias C. 1999. Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors. Eur J Biochem 263: 840-848.
40. Erickson HP, Inglesias JL. 1984. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 311: 267-269.
41. 2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. J Neurosci 22: 7177-7194.
42. Fischer D, Tucker RP, Chiquet-Ehrismann R, Adams JC. 1997. Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol Biol Cell 8: 2055-2075.
43. Fluck M, Mund SI, Schittny JC, Klossner S, Durieux AC, Giraud MN. 2008. Mechano-regulated tenascin-C orchestrates muscle repair. Proc Natl Acad Sci 105: 13662-13667.
44. Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R. 1996. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci 93: 6594-6599.
45. Freitag S, Schachner M, Morellini F. 2003. Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res 145: 189-207.
46. Fujie S, Maita H, Ariga H, Matsumoto K. 2009. Tenascin-X induces cell detachment through p38 mitogen-activated protein kinase activation. Biol Pharm Bull 32: 1795-1799.
47. Fukamauchi F, Mataga N, Wang YJ, Sato S, Youshiki A, Kusakabe M. 1996. Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem Biophys Res Commun 221: 151-156.
48. Fuss B, Wintergerst ES, Bartsch U, Schachner M. 1993. Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: A modular structure similar to tenascin. J Cell Biol 120: 1237-1249.
49. Garcion E, Faissner A, ffrench-Constant C. 2001. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128: 2485-2496.
50. Garcion E, Halilagic A, Faissner A, ffrench-Constant C. 2004. Generation of an environmental niche for neural stem cell development by the extracellular matrix molecule tenascin C. Development 131: 3423-3432.
51. Garwood J, Garcion E, Dobbertin A, Heck N, Calco V, Ffrench-Constan C, Faissner A. 2004. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to plateletderived growth factor. Eur J Neurosci 20: 2524-2540.
52. Ghatnekar A, Trojanowska M. 2008. GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. Biochim Biophys Acta 1779: 145-151.
53. Gherzi R, Leprini A, Siri A, Zardi L. 1998. Structure of 5' region of human tenascin-R gene and characterization of its promoter. DNA Cell Biol 17: 275-282.
54. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. 2010. Transcriptional regulation of the endogenous danger signal tenascin-C: A novel autocrine loop in inflammation. J Immunol 184: 2655-2662.
55. Grumet M, Hoffman S, Crossin KL, Edelman GM. 1985. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci 82: 8075-8079.
56. Gueders MM, Hirst SJ, Quesada-Calvo F, Paulissen G, Hacha J, Gilles C, Gosset P, Louis R, Foidart JM, Lopez-Otin C, et al. 2009. MMP-19 deficiency promotes Tenascin-C accumulation and allergen-induced airway inflammation. Am J Respir Cell Mol Biol 43: 286-295.
57. Guilak F, Cohen DM, Estes BT, Gimble JM, LiedtkeW, Chen CS. 2009. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 5: 17-26.
58. Gundersen D, Tran-Thang C, Sordat B, Mourali F, Ruegg C. 1997. Plasmin-induced proteolysis of tenascin-C:Modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol 158: 1051-1060.
59. Guntinas-Lichius O, Angelov DN, Morellini F, Lenzen M, Skouras E, Schachner M, Irintchev A. 2005. Opposite impacts of tenascin-C and tenascin-R deficiency in mice on the functional outcome of facial nerve repair. Eur J Neurosci 22: 2171-2179.
60. Gurevicius K, Gureviciene I, Valjakka A, Schachner M, Tanila H. 2004. Enhanced cortical and hippocampal neuronal excitability in mice deficient in the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 25: 515-523.
61. Gurevicius K, Kuang F, Stoenica L, Irintchev A, Gureviciene I, Dityatev A, Schachner M, Tanila H. 2009. Genetic ablation of tenascin-C expression leads to abnormal hippocampal CA1 structure and electrical activity in vivo. Hippocampus 19: 1232-1246.
62. Hagios C, Koch M, Spring J, Chiquet M, Chiquet-Ehrismann R. 1996. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J Cell Biol 134: 1499-1512.
63. Haunso A, Ibrahim M, Bartsch U, Letiembre M, Celio MR, Menoud P. 2000. Morphology of perineuronal nets in tenascin-R and parvalbumin single and double knockout mice. Brain Res 864: 142-145.
64. Hecht J, Stricker S, Wiecha U, Stiege A, Panopoulou G, Podsiadlowski L, Poustka AJ, Dieterich C, Ehrich S, Suvorova J, et al. 2008. Evolution of a core gene network for skeletogenesis in chordates. PLoS Genet 4: e1000025.
65. Herlyn M, Graeven U, Speicher D, Sela BA, Bennicelli JL, Kath R, Guerry Dt. 1991. Characterization of tenascin secreted by human melanoma cells. Cancer Res 51: 4853-4858.
66. Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner HH. 2002. Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 98: 362-369.
67. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T. 1993. Expression of tenascin in human gliomas: Its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 85: 481-487.
68. Hirata E, Arakawa Y, Shirahata M, Yamaguchi M, Kishi Y, Okada T, Takahashi JA, Matsuda M, Hashimoto N. 2009. Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue. Cancer Sci 100: 1451-1459.
69. Hoffmann K, Sivukhina E, Potschka H, Schachner M, LoscherW, Dityatev A. 2009. Retarded kindling progression in mice deficient in the extracellular matrix glycoprotein tenascin-R. Epilepsia 50: 859-869.
70. HuangW, Chiquet-Ehrismann R, Moyano JV, Garcia-Pardo A, Orend G. 2001. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res 61: 8586-8594.
71. Huang Z, Wang D, Ihida-Stansbury K, Jones PL, Martin JF. 2009. Defective pulmonary vascular remodeling in Smad8 mutant mice. Hum Mol Genet 18: 2791-2801.
72. Ikeshima-Kataoka H, Shen JS, Eto Y, Saito S, Yuasa S. 2008. Alteration of inflammatory cytokine production in the injured central nervous system of tenascin-deficient mice. In Vivo 22: 409-413.
73. Imai K, Kusakabe M, Sakakura T, Nakanishi I, Okada Y. 1994. Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352: 216-218.
74. Irintchev A, Rollenhagen A, Troncoso E, Kiss JZ, Schachner M. 2005. Structural and functional aberrations in the cerebral cortex of tenascin-C deficient mice. CerebCortex 15: 950-962.
75. Ishii K, Imanaka-Yoshida K, Yoshida T, Sugimura Y. 2008. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation. Dev Biol 324: 310-319.
76. Jahkola T, Toivonen T, Nordling S, von Smitten K, Virtanen I. 1998. Expression of tenascin-C in intraductal carcinoma of human breast: Relationship to invasion. Eur J Cancer 34: 1687-1692.
77. Jahkola T, Toivonen T, von Smitten K, Blomqvist C, Virtanen I. 1996. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer 69: 445-447.
78. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. 2004. Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23: 1656-1667.
79. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. 2006. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol 206: 718-727.
80. Joester A, Faissner A. 2001. The structure and function of tenascins in the nervous system. Matrix Biol 20: 13-22.
81. Jones PL, Jones FS, Zhou B, Rabinovitch M. 1999. Induction of vascular smooth muscle cell tenascin-C gene expression by denatured type I collagen is dependent upon a beta3 integrin-mediated mitogen-activated protein kinase pathway and a 122-base pair promoter element. J Cell Sci 112: 435-445.
82. Jones FS, Meech R, Edelman DB, Oakey RJ, Jones PL. 2001. Prx1 controls vascular smooth muscle cell proliferation and tenascin-C expression and is upregulated with Prx2 in pulmonary vascular disease. Circ Res 89: 131-138.
83. Kazanis I, Belhadi A, Faissner A, Ffrench-Constant C. 2007. The adult mouse subependymal zone regenerates efficiently in the absence of tenascin-C. J Neurosci 27: 13991-13996.
84. Kiernan BW, Garcion E, Ferguson J, Frost EE, Torres EM, Dunnett SB, Saga Y, Aizawa S, Faissner A, Kaur R, et al. 1999. Myelination and behaviour of tenascin-C null transgenic mice. Eur J Neurosci 11: 3082-3092.
85. Kim CH, Bak KH, Kim YS, Kim JM, Ko Y, Oh SJ, Kim KM, Hong EK. 2000. Expression of tenascin-C in astrocytic tumors: Its relevance to proliferation and angiogenesis. Surg Neurol 54: 235-240.
86. Kondo S, Tang Y, Scheef EA, Sheibani N, Sorenson CM. 2008. Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2. Am J Physiol Cell Physiol 294: C1521-C1530.
87. Koyama Y, Kusubata M, Yoshiki A, Hiraiwa N, Ohashi T, Irie S, Kusakabe M. 1998. Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J Invest Dermatol 111: 930-935.
88. Kruse J, Keilhauer G, Faissner A, Timpl R, Schachner M. 1985. The J1 glycoprotein-a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature 316: 146-148.
89. Lange K, Kammerer M, Hegi ME, Grotegut S, Dittmann A, Huang W, Fluri E, Yip GW, Gotte M, Ruiz C, et al. 2007. Endothelin receptor type B counteracts tenascin-Cinduced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization. Cancer Res 67: 6163-6173.
90. Lee HJ, Jakovcevski I, Radonjic N, Hoelters L, Schachner M, Irintchev A. 2009. Better functional outcome of compression spinal cord injury in mice is associated with enhanced H-reflex responses. Exp Neurol 216: 365-374.
91. Leins A, Riva P, Lindstedt R, Davidoff MS, Mehraein P, Weis S. 2003. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer 98: 2430-2439.
92. Leprini A, Gherzi R, Vecchi E, Borsi L, Zardi L, Siri A. 1998. Rat tenascin-R gene: Structure, chromosome location and transcriptional activity of promoter and exon 1. Cytogenet Cell Genet 83: 115-123.
93. Lotz MM, Burdsal CA, Erickson HP, McClay DR. 1989. Cell adhesion to fibronectin and tenascin:Quantitative measurements of initial binding and subsequent strengthening response. J Cell Biol 109: 1795-1805.
94. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. 1987. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 105: 2569-2579.
95. Mai J, Sameni M, Mikkelsen T, Sloane BF. 2002. Degradation of extracellular matrix protein tenascin-C by cathepsin B: An interaction involved in the progression of gliomas. Biol Chem 383: 1407-1413.
96. Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, BristowJ. 2002. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30: 421-425.
97. Martin D, Brown-Luedi M, Chiquet-Ehrismann R. 2003. Tenascin-C signaling through induction of 14-3-3 tau. J Cell Biol 160: 171-175.
98. Martina E, Chiquet-Ehrismann R, Brellier F. 2010. Tenascin-W: An extracellular matrix protein associated with osteogenesis and cancer. Int J Biochem Cell Biol 42: 1412-1415.
99. Martina E, Degen M, Rüegg C, Merlo A, Lino MM, Chiquet-Ehrismann R, Brellier F. 2009. Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro. FASEB J 24: 778-787.
100. Maschler S, Grunert S, Danielopol A, Beug H, Wirl G. 2004. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-β-induced progression of mammary tumor cells. Oncogene 23: 3622-3633.
101. Matsuda A, Hirota T, Akahoshi M, Shimizu M, Tamari M, Miyatake A, Takahashi A, Nakashima K, Takahashi N, Obara K, et al. 2005. Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. Hum Mol Genet 14: 2779-2786.
102. Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M. 1999. Corneal wound healing in tenascin knockout mouse. Invest Ophthalmol Vis Sci 40: 1071-1080.
103. Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M. 2002. Tenascin-C expression and splice variant in habu snake venom-induced glomerulonephritis. Exp Mol Pathol 72: 186-195.
104. Matsumoto K, Minamitani T, Orba Y, Sato M, Sawa H, Ariga H. 2004. Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Exp Cell Res 297: 404-414.
105. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP. 2006. Avian tenascin-W: Expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro. Dev Dyn 235: 1532-1542.
106. Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP. 2008. Effects of tenascin-W on osteoblasts in vitro. Cell Tissue Res 334: 445-455.
107. Mettouchi A, Cabon F, Montreau N, Dejong V, Vernier P, Gherzi R, Mercier G, Binetruy B. 1997. The c-Juninduced transformation process involves complex regulation of tenascin-C expression. Mol Cell Biol 17: 3202-3209.
108. Midwood KS, Orend G. 2009. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3: 287-310.
109. Midwood KS, Schwarzbauer JE. 2002. Tenascin-C modulates matrix contraction via focal adhesion kinase-and Rho-mediated signaling pathways. Mol Biol Cell 13: 3601-3613.
110. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, et al. 2009. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15: 774-780.
111. Midwood KS, Valenick LV, Hsia HC, Schwarzbauer JE. 2004. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol Biol Cell 15: 5670-5677.
112. Minamitani T, Ariga H, Matsumoto K. 2000. Transcription factor Sp1 activates the expression of the mouse tenascin-X gene. Biochem Biophys Res Commun 267: 626-631.
113. Minamitani T, Ariga H, Matsumoto K. 2004a. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. Exp Cell Res 297: 49-60.
114. Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, et al. 2004b. Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp Cell Res 298: 305-315.
115. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. 2005. Genes that mediate breast cancer metastasis to lung. Nature 436: 518-524.
116. Montag-Sallaz M, Montag D. 2003. Severe cognitive and motor coordination deficits in tenascin-R-deficient mice. Genes Brain Behav 2: 20-31.
117. Morel Y, BristowJ, Gitelman SE, Miller WL. 1989. Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. Proc Natl Acad Sci 86: 6582-6586.
118. Morellini F, Schachner M. 2006. Enhanced novelty-induced activity, reduced anxiety, delayed resynchronization to daylight reversal and weaker muscle strength in tenascin-C-deficient mice. Eur JNeurosci 23: 1255-1268.
119. Morellini F, Sivukhina E, Stoenica L, Oulianova E, BukaloO, Jakovcevski I, Dityatev A, Irintchev A, Schachner M. 2010. Improved reversal learning andworking memory and enhanced reactivity to novelty in mice with enhanced GABAergic innervation in the dentate gyrus. Cereb Cortex doi: 101093/cercor/bhq017.
120. Murphy-Ullrich JE. 2001. The de-adhesive activity of matricellular proteins: Is intermediate cell adhesion an adaptive state? J Clin Invest 107: 785-790.
121. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M. 1991. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin [published erratum appears in J Cell Biol 1992 Feb;116:833]. J Cell Biol 115: 1127-1136.
122. Murphy-Ullrich JE, Pallero MA, Boerth N, Greenwood JA, Lincoln TM, Cornwell TL. 1996. Cyclic GMP-dependent protein kinase is required for thrombospondin and tenascin mediated focal adhesion disassembly. J Cell Sci 109: 2499-2508.
123. Nakahara H, Gabazza EC, Fujimoto H, Nishii Y, D'Alessandro-Gabazza CN, Bruno NE, Takagi T, Hayash T, Maruyama J, Maruyama K, et al. 2006. Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse. Eur J Immunol 36: 3334-3345.
124. Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M. 1998. Tenascin-C promotes healing of Habu-snake venominduced glomerulonephritis: Studies in knockout congenic mice and in culture. Am J Pathol 152: 1237-1245.
125. Natali PG, Nicotra MR, Bartolazzi A, Mottolese M, Coscia N, Bigotti A, Zardi L. 1990. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int J Cancer 46: 586-590.
126. Neidhardt J, Fehr S, Kutsche M, Lohler J, Schachner M. 2003. Tenascin-N: Characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants. Mol Cell Neurosci 23: 193-209.
127. Nikonenko A, Schmidt S, Skibo G, Bruckner G, Schachner M. 2003. Tenascin-R-deficient mice show structural alterations of symmetric perisomatic synapses in the CA1 region of the hippocampus. J Comp Neurol 456: 338-349.
128. Nishioka T, Onishi K, Shimojo N, Nagano Y, Matsusaka H, Ikeuchi M, Ide T, Tsutsui H, Hiroe M, Yoshida T, et al. 2010. Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 298: H1072-H1078.
129. NorenbergU, Wille H, Wolff JM, Frank R, Rathjen FG. 1992. The chicken neural extracellular matrix molecule restrictin: Similarity with EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron 8: 849-863.
130. Ohta M, Sakai T, Saga Y, Aizawa S, Saito M. 1998. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 91: 4074-4083.
131. Okamura N, Hasegawa M, Nakoshi Y, Iino T, Sudo A, Imanaka-Yoshida K, Yoshida T, Uchida A. 2010. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage 18: 839-848.
132. Orend G, Chiquet-Ehrismann R. 2006. Tenascin-C induced signaling in cancer. Cancer Lett 244: 143-163.
133. Pesheva P, Spiess E, Schachner M. 1989. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J Cell Biol 109: 1765-1778.
134. Pesheva P, Probstmeier R, Skubitz AP, McCarthy JB, Furcht LT, Schachner M. 1994. Tenascin-R (J1 160/180) inhibits fibronectin-mediated cell adhesion-functional relatedness to tenascin-C. J Cell Sci 107: 2323-2333.
135. Putnam NH, Srivastava M, Hellsten U, Dirks B, Chapman J, Salamov A, Terry A, Shapiro H, Lindquist E, Kapitonov VV, et al. 2007. Sea anemone genome reveals ancestral eumetazoan gene repertoire and genomic organization. Science 317: 86-94.
136. Putthoff P, Akyuz N, Kutsche M, Zardi L, Borgmeyer U, Schachner M. 2003. Structure of the murine tenascin-R gene and functional characterisation of the promoter. Biochem Biophys Res Commun 308: 940-949.
137. Rathjen FG, Wolff JM, Chiquet-Ehrismann R. 1991. Restrictin: A chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. Development 113: 151-164.
138. Reardon DA, Zalutsky MR, Bigner DD. 2007. Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients. Expert Rev Anticancer Ther 7: 675-687.
139. Roth-Kleiner M, Hirsch E, Schittny JC. 2004. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am J Respir Cell Mol Biol 30: 360-366.
140. Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G. 2004. Growth promoting signaling by tenascin-C [corrected]. Cancer Res 64: 7377-7385.
141. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. 1992. Mice develop normally without tenascin. Genes Dev 6: 1821-1831.
142. Saghatelyan AK, Dityatev A, Schmidt S, Schuster T, Bartsch U, Schachner M. 2001. Reduced perisomatic inhibition, increased excitatory transmission, and impaired longterm potentiation in mice deficient for the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 17: 226-240.
143. Sakai T, Furukawa Y, Chiquet-Ehrismann R, Nakamura M, Kitagawa S, Ikemura T, Matsumoto K. 1996. Tenascin-X expression in tumorcells and fibroblasts: Glucocorticoids as negative regulators in fibroblasts. J Cell Sci 109: 2069-2077.
144. Sakai T, Kawakatsu H, Furukawa Y, Saito M. 1995. Regulation of EGF-induced tenascin-C by steroids in tenascin-C non-producing human carcinoma cells. Int J Cancer 63: 720-725.
145. Sarasa-Renedo A, Tunc-Civelek V, Chiquet M. 2006. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain. Exp Cell Res 312: 1361-1370.
146. Sarkar S, Nuttall RK, Liu S, Edwards DR, Yong VW. 2006. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res 66: 11771-11780.
147. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. 2009. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 69: 709-717.
148. Scherberich A, Tucker RP, Degen M, Brown-Luedi M, Andres AC, Chiquet-Ehrismann R. 2005. Tenascin-W is found in malignant mammary tumors, promotes α8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-α induced expression in vitro. Oncogene 24: 1525-1532.
149. Scherberich A, Tucker RP, Samandari E, Brown-Luedi M, Martin D, Chiquet-Ehrismann R. 2004. Murine tenascin-W: A novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J Cell Sci 117: 571-581.
150. Schliemann C, Wiedmer A, Pedretti M, Szczepanowski M, Klapper W, Neri D. 2009. Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma. Leuk Res 33: 1718-1722.
151. Siri A, Knauper V, Veirana N, Caocci F, Murphy G, Zardi L. 1995. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270: 8650-8654.
152. Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC, Zweifel C, Tolnay M, Wasner M, Mergenthaler S, et al. 2009. Tenascin-C is a novel RBPJ kappa-induced target gene for Notch signaling in gliomas. Cancer Res 69: 458-465.
153. Sykova E, Vorisek I, Mazel T, Antonova T, Schachner M. 2005. Reduced extracellular space in the brain of tenascin-R-and HNK-1-sulphotransferase deficient mice. Eur J Neurosci 22: 1873-1880.
154. Tamaoki M, Imanaka-Yoshida K, Yokoyama K, Nishioka T, Inada H, Hiroe M, Sakakura T, Yoshida T. 2005. Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. Am J Pathol 167: 71-80.
155. Tanaka K, Hiraiwa N, Hashimoto H, Yamazaki Y, Kusakabe M. 2004. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int J Cancer 108: 31-40.
156. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. 2008. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
157. Treloar HB, Ray A, Dinglasan LA, Schachner M, Greer CA. 2009. Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J Neurosci 29: 9405-9416.
158. Tsunoda T, Inada H, Kalembeyi I, Imanaka-Yoshida K, Sakakibara M, Okada R, Katsuta K, Sakakura T, Majima Y, Yoshida T. 2003. Involvement of large tenascin-C splice variants in breast cancer progression. Am J
159. Tucker RP. 2001. Abnormal neural crest cell migration after the in vivo knockdown of tenascin-C expression with morpholino antisense oligonucleotides. Dev Dyn 222: 115-119.
160. Tucker RP, Chiquet-Ehrismann R. 2009a. Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int J Biochem Cell Biol 41: 424-434.
161. Tucker RP, Chiquet-Ehrismann R. 2009b. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta 1793: 888-892.
162. Tucker RP, McKay SE. 1991. The expression of tenascin by neural crest cells and glia. Development 112: 1031-1039.
163. Tucker RP, Drabikowski K, Hess JF, Ferralli J, Chiquet-Ehrismann R, Adams JC. 2006. Phylogenetic analysis of the tenascin gene family: Evidence of origin early in the chordate lineage. BMC Evol Biol 6: 60.
164. Wang B, Ling S, LinWC. 2010. 14-3-3Tau regulates Beclin 1 and is required for autophagy. PLoS One 5: e10409.
165. Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, Tanaka T, Kawaguchi S, Wada T, Hata J, et al. 2003. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Genes Chromosomes Cancer 36: 224-232.
166. Weber P, Bartsch U, Rasband MN, Czaniera R, Lang Y, Bluethmann H, Margolis RU, Levinson SR, Shrager P, Montag D, et al. 1999. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci 19: 4245-4262.
167. Weber P, Montag D, Schachner M, Bernhardt RR. 1998. Zebrafish tenascin-W, a new memberof the tenascin family. J Neurobiol 35: 1-16.
168. Wenk MB, Midwood KS, Schwarzbauer JE. 2000. Tenascin-C suppresses Rho activation. J Cell Biol 150: 913-920.
169. Whittaker CA, Bergeron KF, Whittle J, Brandhorst BP, Burke RD, Hynes RO. 2006. The echinoderm adhesome. Dev Biol 300: 252-266.
170. Wijesuriya SD, Bristow J, Miller WL. 2002. Localization and analysis of the principal promoter for human tenascin-X. Genomics 80: 443-452.
171. Williams SA, Schwarzbauer JE. 2009. A shared mechanism of adhesion modulation for tenascin-C and fibulin-1. Mol Biol Cell 20: 1141-1149.
172. Yamada KM, Yamada SS, Pastan I. 1975. The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin. Proc Natl Acad Sci 72: 3158-3162.
173. Yamamoto H, Cho SW, Song SJ, Hwang HJ, Lee MJ, Kim JY, Jung HS. 2005. Characteristic tissue interaction of the diastema region in mice. Arch Oral Biol 50: 189-198.
174. Yamamoto K, Dang QN, Kennedy SP, Osathanondh R, Kelly RA, Lee RT. 1999. Induction of tenascin-C in cardiac myocytes by mechanical deformation. Role of reactive oxygen species. J Biol Chem 274: 21840-21846.
175. Yeh J, Green LM, Jiang TX, Plikus M, Huang E, Chang RN, Hughes MW, Chuong CM, Tuan TL. 2009. Accelerated closure of skinwounds in mice deficient in the homeobox gene Msx2. Wound Repair Regen 17: 639-648.
176. ZagzagD, Friedlander DR, Miller DC, Dosik J, Cangiarella J, Kostianovsky M, Cohen H, Grumet M, Greco MA. 1995. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 55: 907-914.
177. Zhang G, Cohn MJ. 2006. Hagfish and lancelet fibrillar collagens reveal that type II collagen-based cartilage evolved in stem vertebrates. Proc Natl Acad Sci 103: 16829-16833.